FDMT
4D Molecular Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.33
-0.12 ▼ -1.42%
🌙 3월 13일 7:21 PM ET (한국 3/14 08:21)
$8.47
+0.14 ▲ +1.68%
| Index | RUT | P/E | - | EPS (ttm) | -3.94 | Insider Own | 10.88% | Shs Outstand | 0.05B | Perf Week | -1.77% |
| Market Cap | 0.42B | Forward P/E | - | EPS next Y | -6.75% | Insider Trans | -0.23% | Shs Float | 0.05B | Perf Month | -9.95% |
| Enterprise Value | 0.14B | PEG | - | EPS next Q | -0.53 | Inst Own | 97.91% | Short Float | 22.29% | Perf Quarter | -23.08% |
| Income | -0.21B | P/S | 3540.83 | EPS this Y | -9.35% | Inst Trans | 30.14% | Short Ratio | 11.28 | Perf Half Y | 17.82% |
| Sales | 0.00B | P/B | 1.06 | EPS next 5Y | -6.34% | ROA | -40.7% | Short Interest | 10.13M | Perf YTD | 11.07% |
| Book/sh | 7.89 | P/C | 1.39 | EPS past 3/5Y | -5.06% -9.89% | ROE | -45.38% | 52W High | -32.5% ($12.34) | Perf Year | 94.63% |
| Cash/sh | 5.98 | P/FCF | - | Sales past 3/5Y | -87.29% -64.94% | ROIC | -54.25% | 52W Low | 272.71% ($2.23) | Perf 3Y | -52.43% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -43.93% | Gross Margin | -6090.83% | Volatility(W/M) | 6.29% 6.31% | Perf 5Y | -83.47% |
| Dividend TTM | - | EV/Sales | 1184.17 | Sales Y/Y TTM | - | Oper. Margin | -191982.5% | ATR (14) | 0.59 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.42 | EPS Q/Q | -28.41% | Profit Margin | -174314.17% | RSI (14) | 41.76 | Recom | 1.45 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.42 | Sales Q/Q | 2900% | SMA20 | -8.43% ($9.1) | Beta | 3.01 | Target Price | $33.11 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 11000000 | SMA50 | -3.02% ($8.59) | Rel Volume | 0.52 | Prev Close | $8.45 |
| Employees | 227 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | -2.79% -68.74% | SMA200 | 7.7% ($7.73) | Avg Volume(3M) | 0.90M | Price | $8.33 |
| IPO | 2020/12/11 | Option/Short | Yes/Yes | Trades | 5613 | Volume | 466,227 | Change | -1.42% |
뉴스 로딩 중...